{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T06:16:12Z","timestamp":1763273772393,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.nmd.2015.11.001","type":"journal-article","created":{"date-parts":[[2015,11,12]],"date-time":"2015-11-12T09:33:52Z","timestamp":1447320832000},"page":"21-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Functional characterization of the RYR1 mutation p.Arg4737Trp associated with susceptibility to malignant hyperthermia"],"prefix":"10.1016","volume":"26","author":[{"given":"Stephan","family":"Johannsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Treves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemens R.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"M\u00f6gele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Schneiderbanger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Roewer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2015.11.001_bib0010","doi-asserted-by":"crossref","first-page":"w13652","DOI":"10.4414\/smw.2012.13652","article-title":"Malignant hyperthermia","volume":"142","author":"Bandschapp","year":"2012","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.nmd.2015.11.001_bib0015","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1750-1172-2-21","article-title":"Malignant hyperthermia","volume":"2","author":"Rosenberg","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nmd.2015.11.001_bib0020","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/ACO.0b013e328337ffe0","article-title":"Anesthesia for patients with a history of malignant hyperthermia","volume":"23","author":"Wappler","year":"2010","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1016\/j.nmd.2015.11.001_bib0025","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/bja\/56.11.1267","article-title":"A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. The European Malignant Hyperpyrexia Group","volume":"56","author":"Anonymous","year":"1984","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.nmd.2015.11.001_bib0030","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1213\/00000539-198910000-00015","article-title":"Standardization of the caffeine halothane muscle contracture test. North American Malignant Hyperthermia Group","volume":"69","author":"Larach","year":"1989","journal-title":"Anesth Analg"},{"key":"10.1016\/j.nmd.2015.11.001_bib0035","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/bja\/aev225","article-title":"European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility","volume":"115","author":"Hopkins","year":"2015","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.nmd.2015.11.001_bib0040","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/bja\/86.2.283","article-title":"Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia","volume":"86","author":"Urwyler","year":"2001","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.nmd.2015.11.001_bib0045","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1097\/00000542-200405000-00008","article-title":"Molecular genetic testing for malignant hyperthermia susceptibility","volume":"100","author":"Girard","year":"2004","journal-title":"Anesthesiology"},{"key":"10.1016\/j.nmd.2015.11.001_bib0055","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1213\/ANE.0000000000000063","article-title":"DNA testing for malignant hyperthermia: the reality and the dream","volume":"118","author":"Stowell","year":"2014","journal-title":"Anesth Analg"},{"key":"10.1016\/j.nmd.2015.11.001_bib0060","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/00000542-199404000-00008","article-title":"A clinical grading scale to predict malignant hyperthermia susceptibility","volume":"80","author":"Larach","year":"1994","journal-title":"Anesthesiology"},{"key":"10.1016\/j.nmd.2015.11.001_bib0065","first-page":"445","article-title":"Beschreibung eines mit generalisiertem Muskelspasmus und Hyperpyrexie einhergehenden Narkosezwischenfalles","volume":"XXII","author":"Herz","year":"1969","journal-title":"Saarl\u00e4ndisches \u00c4rzteblatt"},{"key":"10.1016\/j.nmd.2015.11.001_bib0070","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1074\/jbc.274.9.5995","article-title":"Skeletal muscle type ryanodine receptor is involved in calcium signaling in human B lymphocytes","volume":"274","author":"Sei","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2015.11.001_bib0075","doi-asserted-by":"crossref","first-page":"48077","DOI":"10.1074\/jbc.M107134200","article-title":"B-lymphocytes from malignant hyperthermia-susceptible patients have an increased sensitivity to skeletal muscle ryanodine receptor activators","volume":"276","author":"Girard","year":"2001","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.nmd.2015.11.001_bib0080","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/bja\/aev225","article-title":"European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility","volume":"115","author":"Hopkins","year":"2015","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.nmd.2015.11.001_bib0085","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1399-6576.2006.01165.x","article-title":"Malignant hyperthermia and central core disease causative mutations in Swedish patients","volume":"51","author":"Broman","year":"2007","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.nmd.2015.11.001_bib0090","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/hmg\/10.25.2879","article-title":"Identification of four novel mutations in the C-terminal membrane spanning domain of the ryanodine receptor 1: association with central core disease and alteration of calcium homeostasis","volume":"10","author":"Tilgen","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2015.11.001_bib0095","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/sj.bjp.0703571","article-title":"Methyl p-hydroxybenzoate (E-218) a preservative for drugs and food is an activator of the ryanodine receptor Ca(2+) release channel","volume":"131","author":"Cavagna","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.nmd.2015.11.001_bib0100","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S0026-895X(25)13345-2","article-title":"Chlorocresol: an activator of ryanodine receptor-mediated Ca2+ release","volume":"44","author":"Zorzato","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.nmd.2015.11.001_bib0105","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1097\/00000542-199606000-00014","article-title":"Chlorocresol, an additive to commercial succinylcholine, induces contracture of human malignant hyperthermia-susceptible muscles via activation of the ryanodine receptor Ca2+ channel","volume":"84","author":"Tegazzin","year":"1996","journal-title":"Anesthesiology"},{"key":"10.1016\/j.nmd.2015.11.001_bib0110","doi-asserted-by":"crossref","first-page":"11040","DOI":"10.1073\/pnas.0905186106","article-title":"Crystal structure of type I ryanodine receptor amino-terminal beta-trefoil domain reveals a disease-associated mutation \u201chot spot\u201d loop","volume":"106","author":"Amador","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nmd.2015.11.001_bib0115","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nature09471","article-title":"The amino-terminal disease hotspot of ryanodine receptors forms a cytoplasmic vestibule","volume":"468","author":"Tung","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.nmd.2015.11.001_bib0120","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0143-4160(02)00138-0","article-title":"Mutations in the RYR1 gene in Italian patients at risk for malignant hyperthermia: evidence for a cluster of novel mutations in the C-terminal region","volume":"32","author":"Galli","year":"2002","journal-title":"Cell Calcium"},{"key":"10.1016\/j.nmd.2015.11.001_bib0125","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/01.anes.0000299431.81267.3e","article-title":"Identification and biochemical characterization of a novel ryanodine receptor gene mutation associated with malignant hyperthermia","volume":"108","author":"Anderson","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1016\/j.nmd.2015.11.001_bib0130","doi-asserted-by":"crossref","first-page":"43838","DOI":"10.1074\/jbc.M403612200","article-title":"Effect of ryanodine receptor mutations on interleukin-6 release and intracellular calcium homeostasis in human myotubes from malignant hyperthermia-susceptible individuals and patients affected by central core disease","volume":"279","author":"Ducreux","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2015.11.001_bib0135","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1097\/00000542-200006000-00040","article-title":"Hypersensitivity of malignant hyperthermia-susceptible swine skeletal muscle to caffeine is mediated by high resting myoplasmic [Ca2+]","volume":"92","author":"Lopez","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1016\/j.nmd.2015.11.001_bib0140","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1096\/fj.12-218354","article-title":"Nonspecific sarcolemmal cation channels are critical for the pathogenesis of malignant hyperthermia","volume":"27","author":"Eltit","year":"2013","journal-title":"FASEB J"},{"key":"10.1016\/j.nmd.2015.11.001_bib0145","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1124\/mol.110.067959","article-title":"Functional and biochemical properties of ryanodine receptor type 1 channels from heterozygous R163C malignant hyperthermia-susceptible mice","volume":"79","author":"Feng","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.nmd.2015.11.001_bib0150","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1172\/JCI993","article-title":"Intracellular calcium homeostasis in human primary muscle cells from malignant hyperthermia-susceptible and normal individuals. Effect of overexpression of recombinant wild-type and Arg163Cys mutated ryanodine receptors","volume":"101","author":"Censier","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nmd.2015.11.001_bib0155","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1034\/j.1399-0004.2002.620206.x","article-title":"Increased sensitivity to 4-chloro-m-cresol and caffeine in primary myotubes from malignant hyperthermia susceptible individuals carrying the ryanodine receptor 1 Thr2206Met (C6617T) mutation","volume":"62","author":"Wehner","year":"2002","journal-title":"Clin Genet"},{"key":"10.1016\/j.nmd.2015.11.001_bib0160","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/humu.20356","article-title":"Mutations in RYR1 in malignant hyperthermia and central core disease","volume":"27","author":"Robinson","year":"2006","journal-title":"Hum Mutat"},{"key":"10.1016\/j.nmd.2015.11.001_bib0165","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/00000542-200606000-00008","article-title":"Malignant hyperthermia in Japan: mutation screening of the entire ryanodine receptor type 1 gene coding region by direct sequencing","volume":"104","author":"Ibarra","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1016\/j.nmd.2015.11.001_bib0170","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00000542-200503000-00007","article-title":"Screening of the entire ryanodine receptor type 1 coding region for sequence variants associated with malignant hyperthermia susceptibility in the North American population","volume":"102","author":"Sambuughin","year":"2005","journal-title":"Anesthesiology"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896615007701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896615007701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:03:59Z","timestamp":1760774639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896615007701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0960896615007701"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2015.11.001","relation":{},"ISSN":["0960-8966"],"issn-type":[{"type":"print","value":"0960-8966"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional characterization of the RYR1 mutation p.Arg4737Trp associated with susceptibility to malignant hyperthermia","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2015.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}